A Phase II Trial of Lutikizumab, an Anti–Interleukin‐1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis
Roy Fleischmann
,
Henning Bliddal
,
Francisco Blanco
,
Thomas Schnitzer
,
Charles Peterfy
,
Su Chen
,
Li Wang
,
Sheng Feng
,
Philip Conaghan
,
Francis Berenbaum
(1)
,
Jean‐pierre Pelletier
,
Johanne Martel-Pelletier
,
Ole Vaeterlein
,
Gurjit Kaeley
,
Wei Liu
,
Matthew Kosloski
,
Gwen Levy
,
Lanju Zhang
,
Jeroen Medema
,
Marc Levesque
Roy Fleischmann
- Function : Author
- PersonId : 817834
- ORCID : 0000-0002-6630-1477
Henning Bliddal
- Function : Author
Francisco Blanco
- Function : Author
- PersonId : 1228363
- ORCID : 0000-0001-9821-7635
Thomas Schnitzer
- Function : Author
Charles Peterfy
- Function : Author
Su Chen
- Function : Author
Li Wang
- Function : Author
Sheng Feng
- Function : Author
Philip Conaghan
- Function : Author
Francis Berenbaum
- Function : Author
- PersonId : 15361
- IdHAL : francis-berenbaum
- ORCID : 0000-0001-8252-7815
- IdRef : 089286774
Jean‐pierre Pelletier
- Function : Author
Johanne Martel-Pelletier
- Function : Author
Ole Vaeterlein
- Function : Author
Gurjit Kaeley
- Function : Author
Wei Liu
- Function : Author
Matthew Kosloski
- Function : Author
Gwen Levy
- Function : Author
Lanju Zhang
- Function : Author
Jeroen Medema
- Function : Author
Marc Levesque
- Function : Author